Bio-Rad Laboratories, Inc. Stock Deutsche Boerse AG
Stocks
BUWA
US0905722072
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 247.00 EUR | -3.52% |
|
-3.74% | -3.44% |
| Jul. 01 | Activist investors make bigger push for campaigns in H1, seek more M&A | RE |
| Jun. 03 | Bio-Rad Laboratories, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 08:45 AM |
| Market Cap | 7.85B 6.87B 6.34B 5.86B 11.12B 750B 11.32B 76B 29.59B 368B 29.47B 28.82B 1,276B | P/E 2026 * |
34.1x | P/E 2027 * | 33.4x |
|---|---|---|---|---|---|
| Enterprise Value | 7.1B 6.22B 5.73B 5.3B 10.06B 678B 10.24B 68.75B 26.77B 333B 26.66B 26.07B 1,154B | EV / Sales 2026 * |
2.77x | EV / Sales 2027 * | 2.61x |
| Free-Float |
60.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Bio-Rad Laboratories, Inc.
| 1 day | -3.52% | ||
| 1 week | -3.74% | ||
| Current month | -3.74% | ||
| 1 month | -2.76% | ||
| 3 months | +3.52% | ||
| 6 months | -10.77% | ||
| Current year | -3.44% |
| 1 week | 247 |  | 262.4 |
| 1 month | 235.8 | | 263.2 |
| Current year | 204.6 | | 278.4 |
| 1 year | 204.6 | | 294.7 |
| 3 years | 187.35 | | 383.8 |
| 5 years | 187.35 | | 700 |
| 10 years | 128.72 | | 700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 76 | 2002-12-31 |
| President | 61 | 2024-09-08 | |
Roop Lakkaraju
DFI | Director of Finance/CFO | 55 | 2024-04-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CHM | Chairman | 76 | 2011-12-31 |
Jeffrey Edwards
BRD | Director/Board Member | 73 | 2017-04-24 |
Gregory Hinckley
BRD | Director/Board Member | 79 | 2017-04-24 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.52% | -3.74% | - | - | 7.85B | |
| -0.69% | +4.89% | -28.81% | -10.50% | 167B | |
| -2.17% | +4.83% | -6.46% | -4.52% | 107B | |
| +1.67% | +9.40% | +2.34% | +62.20% | 59.24B | |
| -6.77% | -7.86% | +44.51% | +46.55% | 52.99B | |
| -3.67% | -0.51% | -12.95% | -41.40% | 43.07B | |
| -6.30% | +2.18% | - | - | 36.37B | |
| +0.67% | +9.96% | -10.71% | -41.55% | 28.39B | |
| -0.67% | -1.48% | +59.69% | -4.82% | 25.16B | |
| -2.04% | +1.90% | -7.08% | +5.37% | 21.17B | |
| Average | -2.35% | +4.89% | +5.07% | +1.42% | 60.07B | |
| Weighted average by Cap. | -1.94% | +5.25% | -4.99% | +1.87% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.57B 2.25B 2.07B 1.92B 3.64B 245B 3.7B 24.86B 9.68B 120B 9.64B 9.43B 417B | 2.63B 2.31B 2.13B 1.97B 3.73B 252B 3.8B 25.52B 9.93B 123B 9.89B 9.68B 428B |
| Net income | 225M 197M 182M 168M 319M 21.48B 324M 2.18B 848M 10.53B 844M 826M 36.55B | 230M 201M 186M 172M 326M 21.95B 331M 2.22B 866M 10.76B 863M 844M 37.34B |
| Net Debt | -749M -656M -605M -559M -1.06B -71.56B -1.08B -7.25B -2.82B -35.09B -2.81B -2.75B -122B | -965M -846M -780M -721M -1.37B -92.24B -1.39B -9.35B -3.64B -45.22B -3.63B -3.55B -157B |
| Date | Price | Change |
|---|---|---|
| 26-07-08 | €247.60 | -3.28% |
| 26-07-07 | €256.00 | -0.54% |
| 26-07-06 | €257.40 | -0.08% |
| 26-07-03 | €257.60 | -0.39% |
| 26-07-02 | €258.60 | -0.69% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIO Stock
- BUWA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
